ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Angelini Licenses Cureverse’s Nov
ScripInsmed Incorporated , Structure Therapeutics, Inc. and Merus N.V. raised more than $1.5bn combined in recent follow-on public offerings (FOPOs), taking advantage of a spike in investor interest an
ScripWhile start-up company financings increased from nearly $2.2bn in the third quarter to $3bn in the fourth quarter, mergers and acquisitions involving young biopharmaceutical companies declined from a
ScripScrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Deal Should Help Gilead “Gly